首页> 外文期刊>Journal of stroke and cerebrovascular diseases: The official journal of National Stroke Association >Tissue Plasminogen Activator to Treat a Stroke after Foam Sclerotherapy in a Woman with a Patent Foramen Ovale
【24h】

Tissue Plasminogen Activator to Treat a Stroke after Foam Sclerotherapy in a Woman with a Patent Foramen Ovale

机译:组织纤溶酶原激活剂治疗泡沫硬化疗法的妇女中的中风疗法,专利ofamen ovale

获取原文
获取原文并翻译 | 示例
           

摘要

Although foam sclerotherapy to varicose veins is now a popular treatment because of its high efficacy and safety, some neurologic complications have recently been reported. Presently, the effectiveness and safety of intravenous recombinant tissue-type plasminogen activator therapy to stroke following foam sclerotherapy remain unclear. Here, we report the case of a 68-year-old woman whose ischemic symptoms following foam sclerotherapy were treated by intravenous recombinant tissue-type plasminogen activator. After she was admitted, the venous thrombosis in her right soleus vein and a patent foramen ovale causing the right-to-left shunt were revealed. Thus, we diagnosed the ischemic symptoms were due to paradoxical embolism following foam sclerotherapy. After intravenous recombinant tissue-type plasminogen activator therapy, there was no complication and the outcome was good. Our case suggests the effectiveness and the safety of intravenous recombinant tissue-type plasminogen activator therapy to paradoxical embolism following foam sclerotherapy.
机译:虽然泡沫硬化治疗静脉曲张静脉现在是一种受欢迎的治疗,但由于其高疗效和安全性,最近报道了一些神经系统并发症。目前,静脉注重重组组织型纤溶酶原治疗在泡沫硬化疗法后脑卒中脑卒中的有效性和安全性仍不清楚。在这里,我们通过静脉注射重组组织型纤维素原激活剂治疗泡沫硬化疗法后缺血性症状的68岁女性的案例。揭示了她被录取后,揭示了她正确的静脉静脉和专利植物卵形卵形卵形卵形卵形的静脉血栓形成。因此,我们诊断出缺血症状是由于泡沫硬化疗法后矛盾的栓塞。在静脉注射重组组织组织型纤溶酶原治疗后,没有并发症,结果良好。我们的案例表明鼻内疗法后静脉注射重组组织型纤溶酶原治疗对矛盾栓塞的有效性和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号